[Back]
Assoz. Prof. Mag. Dr. Verena Pichler
T: +43-1-4277-55624
81 - 100 out of 112
Pichler V, Zenz T, Philippe C, Vraka C, Berrotéran-Infante N, Pfaff S et al. Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method. Nuclear Medicine and Biology. 2018 Dec;67:21-26. doi: 10.1016/j.nucmedbio.2018.09.003
Pichler V, Vraka C, Berroterán-Infante N, Krcal A, Eidherr H, Traub-Weidinger T et al. L-[S-methyl-C-11]methionine - An example of radiosynthetic optimization. Applied Radiation and Isotopes. 2018 Nov;141:107-111. doi: 10.1016/j.apradiso.2018.08.021
Pfaff S, Nehring T, Pichler V, Cardinale J, Mitterhauser M, Hacker M et al. Development and evaluation of a rapid analysis for HEPES determination in 68Ga-radiotracers. EJNMMI Research. 2018 Oct 23;8(1):95. doi: 10.1186/s13550-018-0449-6, 10.1186/s13550-018-0449-6
Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Translational Psychiatry. 2018 Sept 21;8(1):198. doi: 10.1038/s41398-018-0227-2
Pichler V, Berroteran Infante N, Philippe C, Vraka C, Klebermass EM, Balber T et al. An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N. The Journal of Nuclear Medicine. 2018 Sept 1;59(9):1350-1354. doi: 10.2967/jnumed.117.190793
Pfaff S, Philippe C, Pichler V, Hacker M, Mitterhauser M, Wadsak W. Microfluidic 68Ga-labeling: A proof of principle study. Dalton Transactions. 2018 May 7;47(17):5997-6004. doi: 10.1039/c8dt00158h
Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J et al. Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers. NeuroImage. 2018 May 1;171:1-5. doi: 10.1016/j.neuroimage.2017.12.092
Spies M, James GM, Berroterán-Infante N, Ibeschitz H, Kranz GS, Unterholzner J et al. Assessment of Ketamine binding of the serotonin transporter in humans with positron emission tomography. International Journal of Neuropsychopharmacology. 2018 Feb;21(2):145–153. doi: 10.1093/ijnp/pyx085
Kowol C, Heffeter P, Berger W, Keppler B, Mayr J, Pichler V, inventors. MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY. WO2017097986 A1. 2017 Jun 15.
Goeschl S, Schreiber-Brynzak E, Pichler V, Cseh K, Heffeter P, Jungwirth U et al. Comparative studies of oxaliplatin-based platinum(IV) complexes in different in vitro and in vivo tumor models. Metallomics: integrated biometal science. 2017 Mar 22;9(3):309-322. doi: 10.1039/c6mt00226a
Hackl CM, Legina MS, Pichler V, Schmidlehner M, Roller A, Domotor O et al. Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior. Chemistry: A European Journal. 2016 Nov 21;22(48):17269-17281. doi: 10.1002/chem.201603206
Schreiber-Brynzak E, Pichler V, Heffeter P, Hanson B, Theiner S, Lichtscheidl-Schultz I et al. Behavior of platinum(IV) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation. Metallomics: integrated biometal science. 2016 Apr;8(4):422-433. doi: 10.1039/c5mt00312a
Schmidlehner M, Pichler V, Roller A, Jakupec MA, Kandioller W, Keppler BK. Organometallic complexes of (thio)allomaltol-based Mannich-products: Synthesis, stability and preliminary biological investigations. Journal of Organometallic Chemistry. 2015 Apr 15;782:69-76. doi: 10.1016/j.jorganchem.2014.10.044
Kuhn PS, Pichler V, Roller A, Hejl M, Jakupec MA, Kandioller W et al. Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential. Dalton Transactions. 2015;44(2):659-668. doi: 10.1039/c4dt01645a
Pichler V, Goeschl S, Schreiber-Brynzak E, Jakupec MA, Galanski MS, Keppler BK. Influence of reducing agents on the cytotoxic activity of platinum(IV) complexes: induction of G(2)/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines. Metallomics: integrated biometal science. 2015;7(7):1078-1090. doi: 10.1039/c5mt00116a
Karnthaler-Benbakka C, Groza D, Kryeziu K, Pichler V, Roller A, Berger W et al. Tumor-Targeting of EGFR Inhibitors by Hypoxia-Mediated Activation. Angewandte Chemie (International Edition). 2014 Nov 17;53(47):12930-12935. doi: 10.1002/anie.201403936
Brynzak E, Heffeter P, Pichler V, Jakupec MA, Keppler BK. Behaviour of platinum(IV) complexes with prodrug function in different models of hypoxia. European Journal of Cancer. 2014 Nov;50:53-53.
Goeschl S, Pichler V, Brynzak E, Heffeter P, Jungwirth U, Jakupec MA et al. Platinum(IV) derivatives of oxaliplatin: Cellular effects and in vivo potency. European Journal of Cancer. 2014 Nov;50:22-22.
Karnthaler-Benbakka C, Groza D, Kryeziu K, Pichler V, Roller A, Berger W et al. A cobalt-based strategy for tumor targeting of EGFR-inhibitors. Journal of Biological Inorganic Chemistry. 2014 Aug;19:S803-S803.
Kuhn PS, Pichler V, Roller A, Jakupec M, Kandioller W, Keppler BK. Improved reaction conditions for the synthesis of novel KP1339 derivatives and preliminary investigations on their anticancer potential. Journal of Biological Inorganic Chemistry. 2014 Aug;19:S801-S801.
81 - 100 out of 112

Sanggenons for inhalation? Biopharmaceutical profiling of anti-infectives from Morus alba root bark

Adelsberger, S. (Speaker), Schwarzinger, J. (Contributor), Ortmayr, K. (Contributor), Stellnberger, S. (Contributor), Tahir, A. (Contributor), Hädrich, G. (Contributor), Pichler, V. (Contributor), Rollinger, J. M. (Contributor), Dailey, L. A. (Contributor) & Grienke, U. (Contributor)

4 Jul 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Back-to-basics II: Computational methods in radio-pharmaceutical sciences

Pichler, V. (Speaker)

2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

The beautiful world of radiopharmaceuticals

Pichler, V. (Speaker)

2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Research Club, Accumulation of micro- and nanoplastic in colorectal cancer cells

Pichler, V. (Speaker)

13 Dec 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

How to label micro- and nanoplastic

Pichler, V. (Speaker)

27 Sept 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Lecture: Medicinal Radiochemistry

Pichler, V. (Speaker)

17 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

FFG Project Spheriograph, Dynamic 3D cell culture method

Pichler, V. (Speaker)

2 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Strategies for 18-Fluorine labelling of exendin-4

Pichler, V. (Speaker)

1 Mar 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Isotopes' Availability

Pichler, V. (Speaker)

22 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

First-in-human brain imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1 PET

Rischka, L. (Speaker), Vraka, C. (Contributor), Pichler, V. (Contributor), Rasul, S. (Contributor), Nics, L. (Contributor), Gryglewski, G. (Contributor), Handschuh, P. A. (Contributor), Murgaš, M. (Contributor), Godbersen, G. N. (Contributor), Silberbauer, L. (Contributor), Unterholzner, M. (Contributor), Wotawa, C. (Contributor), Haider, A. (Contributor), Ahmed, H. (Contributor), Schibli, R. (Contributor), Mindt, T. (Contributor), Mitterhauser, M. (Contributor), Wadsak, W. (Contributor), Hahn, A. (Contributor), Lanzenberger, R. (Contributor), Hacker, M. (Contributor) & Ametamey, S. M. (Contributor)

20 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Imaging Probes based on Small Molecules with Emphasis on PET

Pichler, V. (Speaker)

24 Aug 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture

Pichler, V. (Speaker)

17 May 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Differences and similarities between symmetrically and unsymmetrically substituted PtIV complexes with N,(N)-(di)alkylethane-1,2-diamine ligands

Pichler, V. (Speaker)

8 Sept 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Department of Pharmaceutical Sciences

Strahlenschutzbeauftragte

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E306

T: +43-1-4277-55624

verena.pichler@univie.ac.at